PDF(490 KB)
PDF(490 KB)
PDF(490 KB)
医学科技颠覆性技术展望
Prospect of Medical Disruptive Technologies
随着医学与现代信息技术、材料科技等技术的深度交叉融合，极大地促进了医学科技的发展，疾病诊断和治疗模式发生革命性的变化。本文主要从医学领域的肿瘤免疫治疗、基因编辑技术、医学人工智能、合成生物学技术和干细胞与转化医学五个技术方向，分析评价其发展态势；结合文献、智库报告和专家观点，对医学科技发展方向进行初探，提出重视医学基础研究投入、优化医学科技战略顶层设计、完善政策及监管体系等政策建议。
With the deep integration of modern information, materials and other technologies, the development of medical science and technology has been greatly promoted, and the way of disease diagnosis and treatment has undergone revolutionary changes. This paper mainly analyzes and evaluates five technical directions in tumor immunotherapy, gene editing technology, medical artificial intelligence, synthetic biology, and stem cell and translational medicine. Combining literature, think tank reports and expert opinions, the paper explores the direction of medical science and technology development. Finally, the paper puts forward the policy proposals including increasing investment in basic medical research, optimizing the top-level design of medical science and technology strategy, and improving policy and regulatory systems.
medical technology / disruptive technology / tumor immunotherapy / gene editing
| [1] |
曹雪涛. 建好医学科技创新体系核心基地 [N]. 人民日报, 2017- 11-21 (13). Cao X T. Establishing the core base of medical science and technology innovation system [N]. People’s Daily, 2017-11-21 (13).
|
| [2] |
邱志敏, 王玲, 傅颖媛. 免疫检查点PD-1/PD-L1 抑制剂在恶性 肿瘤中的治疗进展 [J]. 实用癌症杂志, 2018, 33(5): 868–870. Qiu Z M, Wang L, Fu Y Y. Treatment progress in malignant tumors with immune checkpoint PD-1/PD-L1 inhibitor [J]. The Practical Journal of Cancer, 2018, 33(5): 868–870.
|
| [3] |
Liang P, Xu Y, Zhang X, et al. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes [J]. Protein & Cell, 2015, 6(5): 363–372.
|
| [4] |
Kang X, He W, Huang Y, et al. Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing [J]. Journal of Assisted Reproduction and Genetics, 2016, 33(5): 581–588.
|
| [5] |
Ma H, Marti-Gutierrez N, Park S W, et al. Correction of a pathogenic gene mutation in human embryos [J]. Nature, 2017, 548 (7668): 413–419.
|
| [6] |
王海星, 田雪晴, 游茂, 等. 人工智能在医疗领域应用现状、问 题及建议 [J]. 卫生软科学, 2018, 32(5): 3–5. Wang H X, Tian X Q, You M, et al. Application status, problems and suggestions of artificial intelligence in medical field [J]. Soft Science of Health, 2018, 32(5): 3–5.
|
| [7] |
亿欧智库. 2017 人工智能赋能医疗产业研究报告 [R]. 北京: 亿 欧智库, 2017. Iyiou Think Tank. Research report on artificial intelligence enabling medical industry (2017) [R]. Beijing: Iyiou Think Tank, 2017.
|
| [8] |
Shao Y, Lu N, Wu Z, et al. Creating a functional single-chromosome yeast [J]. Nature, 2018, 560(7718): 331–335.
|
| [9] |
王玥, 许丽, 施慧琳. 从专利角度分析国际干细胞技术研发态势 [J]. 竞争情报, 2017, 13(3): 43–50. Wang Y, Xu L, Shi H L. On development and trends of stem cells technology from perspective of patent [J]. Competitive Intelligence, 2017, 13(3): 43–50.
|
| [10] |
Augustyn J. Emerging science and technology trends: 2016—2045. A synthesis of leading forecasts [R]. USA: Office of the Deputy Assistant Secretary of the Army (Research & Technology), 2016.
|
| [11] |
李政, 刘春平, 罗晖. 浅析颠覆性技术的内涵与培育——重视颠 覆性技术背后的基础科学研究 [J]. 全球科技经济瞭望, 2016, 31(10): 53–61. Li Z, Liu C P, Luo H. Elementary analysis the connotation and cultivation of disruptive technology—Focus on basic scientific research behind disruptive technologies [J]. Global Science, Technology and Economy Outlook, 2016, 31(10): 53–61.
|
/
| 〈 |
|
〉 |
